Does TOFACITINIB Cause Haematochezia? 1,118 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,118 reports of Haematochezia have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.7% of all adverse event reports for TOFACITINIB.
1,118
Reports of Haematochezia with TOFACITINIB
0.7%
of all TOFACITINIB reports
5
Deaths
160
Hospitalizations
How Dangerous Is Haematochezia From TOFACITINIB?
Of the 1,118 reports, 5 (0.4%) resulted in death, 160 (14.3%) required hospitalization, and 4 (0.4%) were considered life-threatening.
Is Haematochezia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 1,118 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Haematochezia?
VEDOLIZUMAB (5,215)
ADALIMUMAB (4,008)
INFLIXIMAB (3,539)
ASPIRIN (2,379)
RIVAROXABAN (1,623)
MESALAMINE (1,456)
CLOPIDOGREL BISULFATE (1,390)
APIXABAN (1,312)
METHOTREXATE (1,133)
PREDNISONE (994)
Which TOFACITINIB Alternatives Have Lower Haematochezia Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN